Kate Haviland

Former CEO of Blueprint Medicines and biotech executive experienced in building and scaling companies; led Blueprint's transition from precision oncology toward precision immunology and guided its acquisition by Sanofi.

Best podcasts with Kate Haviland

Ranked by the Snipd community

10 snips

Jan 8, 2026 • 1h 26min

Ep192: Kate Haviland on Following the Science to Precision Immunology

Kate Haviland, former CEO of Blueprint Medicines, shares her journey from a Glens Falls childhood to leading a $9.5 billion biotech acquisition by Sanofi. She discusses the strategic shift to precision immunology and highlights the importance of commercial thinking in drug development. Insights on patient engagement and the success of Avapritinib for rare cancers reveal her leadership philosophy. Haviland also emphasizes how a strong culture and adaptability contributed to navigating challenges and securing a successful partnership with Sanofi.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app